# Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo

> **NCT01766609** · PHASE2 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 18 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT01766609
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-10
- **Final completion:** 2016-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2015-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766609, "Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01766609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*